Gene · 6139
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049326 | PubTator, text mining | PubMed |
| Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup. | Front Immunol | 2023 | 38035100 | PubTator, text mining | PubMed |
| Dermis resident macrophages orchestrate localized ILC2 eosinophil circuitries to promote non-healing cutaneous leishmaniasis. | Nat Commun | 2023 | 38030609 | PubTator, text mining | PubMed |
| Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing. | Front Immunol | 2023 | 38022625 | PubTator, text mining | PubMed |
| MUC15 is an independent prognostic factor that promotes metastases of MYCN non-amplified neuroblastoma. | J Cancer | 2023 | 38021164 | PubTator, text mining | PubMed |
| Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. | BMC Cancer | 2023 | 38017425 | PubTator, text mining | PubMed |
| Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases. | Int J Mol Sci | 2023 | 38003338 | PubTator, text mining | PubMed |
| CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications. | Biomedicines | 2023 | 38001911 | PubTator, text mining | PubMed |
| SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer. | Biomedicines | 2023 | 38001885 | PubTator, text mining | PubMed |
| Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. | Cancers (Basel) | 2023 | 38001750 | PubTator, text mining | PubMed |
| Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics. | bioRxiv | 2023 | 37986917 | PubTator, text mining | PubMed |
| Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis. | J Transl Med | 2023 | 37978524 | PubTator, text mining | PubMed |
| COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. | BMC Gastroenterol | 2023 | 37974070 | PubTator, text mining | PubMed |
| DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer. | Transl Cancer Res | 2023 | 37969400 | PubTator, text mining | PubMed |
| Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence. | Front Oncol | 2023 | 37965470 | PubTator, text mining | PubMed |
| Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. | Front Immunol | 2023 | 37965344 | PubTator, text mining | PubMed |
| Big data- and machine learning-based analysis of a global pharmacovigilance database enables the discovery of sex-specific differences in the safety profile of dual IL4/IL13 blockade. | Front Pharmacol | 2023 | 37954855 | PubTator, text mining | PubMed |
| Memory regulatory T cells in pregnancy. | Front Immunol | 2023 | 37954599 | PubTator, text mining | PubMed |
| TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification. | Aging (Albany NY) | 2023 | 37950731 | PubTator, text mining | PubMed |
| Comprehensive characterization of TGFB1 across hematological malignancies. | Sci Rep | 2023 | 37925591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6139/papers?page=8